Daniel Piacquadio is a Dermatology physician affiliated with Therapeutics Clinical Research. OpenAlex indexes 41 publications with 1,657 citations (h-index 18); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9025 Balboa Ave
Suite 105
San Diego, CA 921231520
Telephone
858-571-6800Registry record last updated 7 Mar 2023.
Clinical trials
- Study of TDM-180935 in Atopic Dermatitis Patients
Sponsor: Technoderma Medicines Inc.
- Study of TDM-105795 Following Topical Administration in Male Subjects With Androgenetic Alopecia
Sponsor: Technoderma Medicines Inc.
- A Phase 1 Study of TDM-180935 Following Topical Administration in Healthy Male Subjects
Sponsor: Technoderma Medicines Inc.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Galderma Laboratories, L.P.Program year20251 payment
- PFIZER INC.Program year20241 payment
- PFIZER INC.Program year20232 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Treatment Satisfaction and Acceptability of 20% Aminolevulinic Acid Photodynamic Therapy for the Treatment of Actinic Keratoses of the Face, Scalp, and Upper Extremities.
PubMed
2023 - 25988 Acceptability of 20% aminolevulinic acid photodynamic therapy for treatment of actinic keratoses on the upper extremities in a phase 3, randomized, vehicle-controlled trial
Journal of the American Academy of Dermatology
2021 - A Randomized Trial of Broad Area ALA–PDT for Field Cancerization Mitigation in High-Risk Patients
Journal of Drugs in Dermatology
2020 - A Randomized Trial of Broad Area ALA–PDT for Field Cancerization Mitigation in High-Risk Patients
Journal of Drugs in Dermatology
2020
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”